Health Law Grand Rounds

October 30, 2014
Health Law Grand Rounds
Religious Conscience in Health Care: What Hobby Lobby Teaches Us

Speaker: Professor Robin Fretwell Wilson, Roger and Stephany Joslin Professor of Law and Director, Family Law and Policy Program, University of Illinois College of Law
Time: 1:00pm
Location: Wynne Courtroom (Room 100), Inlow Hall, 530 W. New York Street, Indianapolis, IN

PLEASE NOTE NEW DATE of October 30th! The Hall Center for Law and Health presents Health Law Grand Rounds with Professor Robin Fretwell Wilson, Roger and Stephany Joslin Professor of Law and Director, Family Law and Policy Program, University of Illinois College of Law. She will speak on "Religious Conscience in Health Care:  What Hobby Lobby Teaches Us."

[Full Details...]  


Past Grand Rounds

September 4, 2014
Irrational Hospital Prices
Speaker: Professor Erin Fuse Brown, Assistant Professor of Law, Georgia State University College of Law
 
March 6, 2014
Analyzing the Existing FDA Regulatory Framework for New Products: A case study focusing on Probiotics
Speaker: Professor Diane Hoffmann, University of Maryland Carey School of Law, Director, Law and Health Care Program
 
December 3, 2013
French Health Law
Speaker: Professor Prof. Anne-Marie Duguet, Senior Lecturer at the Medicine Faculty Toulouse Purpan (Paul Sabatier University)
 
October 31, 2013
Statutory Interpretation and the Affordable Care Act
Speaker: Professor Nicholas Bagley, University of Michigan Law School
 
March 27, 2013
The Future of Health Law
Speaker: Professor Peter Jacobson, University of Michigan School of Public Health
 
November 8, 2012
The Obamacare Litigation and the Intersection of Liberty, Federalism, and Democracy
Speaker: Professor Abigail Moncrieff, Boston University
 
October 4, 2012
Implications of National Federation of Independent Business v. Sebelius
Speaker: Professor Nicole Huberfeld, University of Kentucky
 
February 22, 2012
A Perspective on Medical Device and Radiological Health Regulations and Career Opportunities
Speaker: Dr. Jeff Shuren, Federal Drug Administration (FDA)